← Back
Data updated: Mar 10, 2026
INFORLIFE
CardiovascularInfectious Disease
INFORLIFE is a generic drug manufacturer focused on Cardiovascular, Infectious Disease. Key products include MIDAZOLAM IN 0.9% SODIUM CHLORIDE.
2008
Since
11
Drugs
-
Trials
59
Approved (2yr)
Key Drugs
NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE
nicardipine hydrochloride
Calcium channel 2 indications · 2024
NICARDIPINE HYDROCHLORIDE IN 0.83% SODIUM CHLORIDE
nicardipine hydrochloride
Calcium channel 2 indications · 2024
MIDAZOLAM IN 0.9% SODIUM CHLORIDE
midazolam
2 indications · 2021
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
norepinephrine bitartrate
alpha-adrenergic receptor 1 indications · 2022
Recent Activity
ZOLEDRONIC ACID 2026-02-05
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 2026-01-14
Labeling
ACETAMINOPHEN 2025-12-05
ZOLEDRONIC ACID 2025-08-15
Labeling
ROPIVACAINE HYDROCHLORIDE 2025-08-06
Labeling
ROPIVACAINE HYDROCHLORIDE 2025-08-06
Labeling
ZOLEDRONIC ACID 2025-07-30
Labeling
MIDAZOLAM IN 0.9% SODIUM CHLORIDE 2025-06-23
Labeling
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 2025-04-25
Labeling
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER 2025-04-25
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 67%
2 drugs
Infectious Disease 33%
1 drugs
Pipeline Strength Pro
Loading...
Active (5)
Discontinued (6)
Company Info
- First Approval
- 2008-03-18
- Latest
- 2025-08-15
- Applications
- 11